• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    ReportInfographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Breast Cancer Core Needle Biopsy Market

    ID: MRFR/HC/27391-HCR
    128 Pages
    Rahul Gotadki
    September 2025

    Breast Cancer Core Needle Biopsy Market Research Report By Target Tissue (Breast, Prostate, Lung, Liver, Kidney), By Needle Size (14-Gauge, 16-Gauge, 18-Gauge, 20-Gauge, 22-Gauge), By Modality (Ultrasound-Guided, Stereotactic, Other), By Procedure Type (Outpatient, Inpatient), By Biopsy Device Type (Vacuum-Assisted, Spring-Loaded, Gravity-Fed) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2032

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Breast Cancer Core Needle Biopsy Market Research Report — Global Forecast till 2032 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    Breast Cancer Core Needle Biopsy Market Summary

    The Global Breast Cancer Core Needle Biopsy Market is projected to grow from 0.4 USD Billion in 2024 to 0.69 USD Billion by 2035.

    Key Market Trends & Highlights

    Breast Cancer Core Needle Biopsy Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 5.05% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 0.69 USD Billion, indicating robust growth.
    • In 2024, the market is valued at 0.4 USD Billion, laying a strong foundation for future expansion.
    • Growing adoption of core needle biopsy techniques due to increasing awareness of early breast cancer detection is a major market driver.

    Market Size & Forecast

    2024 Market Size 0.4 (USD Billion)
    2035 Market Size 0.69 (USD Billion)
    CAGR (2025-2035) 5.05%

    Major Players

    Hologic, Inc., BD (Becton, Dickinson and Company), Invivo Medical, AngioDynamics, Cook Medical, Carl Zeiss, EndoClot Plus, Argon Medical Devices, R. Bard, Medicsight Telemedicine Technology, Cianna Medical, Devicor Medical Products, Olympus, Leica Biosystems, FUJIFILM Holdings

    Breast Cancer Core Needle Biopsy Market Trends

    The rising incidence of breast cancer, growing awareness of early detection techniques, and technological advancements in core needle biopsy drive the global breast cancer core needle biopsy market. Minimally invasive procedures, improved diagnostic accuracy, and increasing healthcare expenditure further contribute to market growth.

    Trends in recent times include the adoption of vacuum-assisted breast biopsy (VABB) for improved sample collection, advancements in ultrasound-guided core needle biopsy (US-CNB) for real-time visualization, and the emergence of automated core needle biopsy devices for enhanced precision and accuracy.

    Opportunities for market expansion exist in developing regions with limited access to advanced healthcare facilities, the integration of artificial intelligence (AI) for better image analysis, and the development of molecular biomarkers to guide treatment decisions.

     

    The increasing emphasis on early detection and minimally invasive procedures in breast cancer diagnostics appears to be driving the adoption of core needle biopsy techniques across healthcare systems globally.

    U.S. National Cancer Institute

    Breast Cancer Core Needle Biopsy Market Drivers

    Market Growth Projections

    The Global Breast Cancer Core Needle Biopsy Market Industry is projected to experience robust growth over the next decade. With an estimated market value of 0.4 USD Billion in 2024, it is expected to reach 0.69 USD Billion by 2035, reflecting a compound annual growth rate of 5.05% from 2025 to 2035. This growth is driven by various factors, including rising breast cancer incidence, technological advancements, and increasing awareness of early detection. The market's expansion indicates a strong demand for core needle biopsy procedures, positioning it as a vital component in breast cancer diagnostics.

    Rising Incidence of Breast Cancer

    The increasing incidence of breast cancer globally serves as a primary driver for the Global Breast Cancer Core Needle Biopsy Market Industry. According to the World Health Organization, breast cancer remains the most commonly diagnosed cancer among women, with millions of new cases reported annually. This trend necessitates the development and adoption of effective diagnostic tools, such as core needle biopsies, which provide accurate tissue sampling. As the number of breast cancer cases rises, the demand for minimally invasive procedures like core needle biopsies is expected to grow, contributing to the market's projected value of 0.4 USD Billion in 2024 and an anticipated increase to 0.69 USD Billion by 2035.

    Government Initiatives and Funding

    Government initiatives aimed at combating breast cancer are playing a crucial role in shaping the Global Breast Cancer Core Needle Biopsy Market Industry. Various countries are implementing policies to enhance cancer care, including funding for research and development of diagnostic technologies. These initiatives often lead to increased accessibility of core needle biopsy procedures, making them more widely available to patients. As governments allocate resources to improve healthcare infrastructure and support cancer research, the market is likely to benefit from enhanced investment and innovation, further propelling its growth trajectory.

    Increasing Awareness and Screening Programs

    Growing awareness about breast cancer and the importance of early detection is driving the Global Breast Cancer Core Needle Biopsy Market Industry. Public health campaigns and screening programs are encouraging women to undergo regular mammograms and biopsies, leading to earlier diagnosis and treatment. This heightened awareness is reflected in the rising number of women participating in screening initiatives, which subsequently increases the demand for core needle biopsies. As more women are educated about their health, the market is expected to grow, aligning with the projected increase in market value from 0.4 USD Billion in 2024 to 0.69 USD Billion by 2035.

    Technological Advancements in Biopsy Techniques

    Technological innovations in biopsy techniques are significantly influencing the Global Breast Cancer Core Needle Biopsy Market Industry. Advancements such as ultrasound-guided biopsies and automated biopsy devices enhance the precision and efficiency of tissue sampling. These innovations not only improve patient outcomes but also reduce the risk of complications associated with traditional biopsy methods. As healthcare providers increasingly adopt these advanced technologies, the market is likely to experience substantial growth. The projected compound annual growth rate of 5.05% from 2025 to 2035 underscores the potential for further expansion driven by these technological advancements.

    Patient Preference for Minimally Invasive Procedures

    The growing preference for minimally invasive procedures among patients is a significant driver of the Global Breast Cancer Core Needle Biopsy Market Industry. Patients increasingly seek options that minimize discomfort and recovery time, making core needle biopsies an attractive choice compared to traditional surgical biopsies. This shift in patient preference is influencing healthcare providers to adopt less invasive techniques, thereby expanding the market. As the demand for patient-centered care continues to rise, the market is expected to flourish, reflecting the anticipated growth in value from 0.4 USD Billion in 2024 to 0.69 USD Billion by 2035.

    Market Segment Insights

    Breast Cancer Core Needle Biopsy Market Target Tissue Insights

    The Global Breast Cancer Core Needle Biopsy Market is segmented into various segments including Target Tissue. Target Tissue is categorizing the market into Breast, Prostate, Lung, Liver, Kidney and others. Among them, Breast segment held the largest share of the market in 2023.

    The high prevalence of breast cancer and the increasing adoption of core needle biopsies for breast cancer diagnosis are major factors driving the growth of this segment. The increasing awareness of breast cancer and the importance of early detection are also contributing to the growth of the Breast segment.

    The Prostate segment is also expected to witness significant growth over the forecast period. The increasing incidence of prostate cancer and the growing adoption of core needle biopsies for prostate cancer diagnosis are major factors driving the growth of this segment.

    The Lung segment is expected to grow at a moderate rate during the forecast period due to the rising incidence of lung cancer and the increasing adoption of core needle biopsies for lung cancer diagnosis. The Liver segment is expected to grow at a steady pace over the forecast period.

    The Kidney segment is expected to grow at a moderate rate due to the rising incidence of kidney cancer and the increasing adoption of core needle biopsies for kidney cancer diagnosis.

    Breast Cancer Core Needle Biopsy Market Needle Size Insights

    The Global Breast Cancer Core Needle Biopsy Market is segmented by needle size, with options including 14-Gauge, 16-Gauge, 18-Gauge, 20-Gauge, and 22-Gauge. Among these, the 14-Gauge needle segment holds a significant market share due to its ability to provide larger tissue samples, leading to more accurate diagnoses.

    The 16-Gauge and 18-Gauge needle segments follow closely, offering a balance between sample size and patient comfort. The 20-Gauge and 22-Gauge needle segments are preferred for less invasive procedures and are gaining traction in outpatient settings.

    The Global Breast Cancer Core Needle Biopsy Market revenue is expected to witness substantial growth in the coming years, driven by factors such as increasing breast cancer incidence, technological advancements, and rising healthcare expenditure.

    Breast Cancer Core Needle Biopsy Market Modality Insights

    The Global Breast Cancer Core Needle Biopsy Market segmentation by Modality includes Ultrasound-Guided, Stereotactic, and Other. Ultrasound-Guided segment held the largest market share of 42.1% in 2023 and is expected to continue its dominance throughout the forecast period.

    The increasing adoption of ultrasound-guided core needle biopsy due to its accuracy, real-time visualization, and cost-effectiveness contributes to its market dominance. The stereotactic segment is projected to witness a significant growth rate of 8.2% during the forecast period, owing to the rising demand for minimally invasive procedures and technological advancements in stereotactic systems.

    Other segments, which includes MRI-guided and vacuum-assisted core needle biopsy, is expected to grow steadily due to the expanding applications and improved accuracy of these techniques.

    Breast Cancer Core Needle Biopsy Market Procedure Type Insights

    The Global Breast Cancer Core Needle Biopsy Market is segmented by Procedure Type into Outpatient and Inpatient. Outpatient procedures account for a larger share of the market due to the increasing adoption of minimally invasive procedures and the convenience it offers to patients.

    The rising number of outpatient surgery centers and the growing preference for same-day surgeries further contribute to the growth of this segment. Inpatient procedures, on the other hand, are preferred for complex cases that require specialized equipment or extended monitoring.

    Despite the growing popularity of outpatient procedures, inpatient procedures are expected to maintain a steady share in the market due to the need for specialized care in certain cases. The Global Breast Cancer Core Needle Biopsy Market revenue from Outpatient procedures is projected to reach 2.65 billion USD by 2024.

    Breast Cancer Core Needle Biopsy Market Biopsy Device Type Insights

    The Global Breast Cancer Core Needle Biopsy Market is segmented by Biopsy Device Type into Vacuum-Assisted, Spring-Loaded, and Gravity-Fed. By 2024, the Vacuum-Assisted segment is projected to have a dominant market share, driven by the advantages it offers, including accurate tissue sampling, ease of use, and reduced patient discomfort.

    Spring-Loaded devices are anticipated to hold a notable market share due to their precision and reliability in obtaining tissue samples. Gravity-Fed devices, while holding a smaller market share, are expected to witness steady growth due to their cost-effectiveness and simplicity of use.

    The Global Breast Cancer Core Needle Biopsy Market is expected to grow significantly in the coming years, with increasing awareness about early detection and diagnosis of breast cancer, technological advancements, and supportive government initiatives.

    Get more detailed insights about Breast Cancer Core Needle Biopsy Market Research Report — Global Forecast till 2032

    Request Free Sample

    Regional Insights

    The Global Breast Cancer Core Needle Biopsy Market is segmented into North America, Europe, Asia Pacific, South America, and Middle East Africa. North America is expected to hold the largest market share in 2023, owing to the high prevalence of breast cancer and the increasing adoption of core needle biopsy procedures. Europe is expected to be the second-largest market, followed by Asia Pacific.

    The Asia Pacific region is expected to witness the fastest growth rate during the forecast period, due to the rising incidence of breast cancer and the increasing awareness of core needle biopsy procedures. South America and Middle East Africa are expected to contribute a smaller share to the global market.

    Breast Cancer Core Needle Biopsy Market Regional Insights

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

     

    Key Players and Competitive Insights

    Major players in the Breast Cancer Core Needle Biopsy Market industry are continuously investing in research and development to enhance their product offerings and expand their market share. Leading Breast Cancer Core Needle Biopsy Market players are focused on developing innovative technologies and solutions to meet the evolving needs of healthcare professionals and patients.

    The Breast Cancer Core Needle Biopsy Market development is driven by the increasing prevalence of breast cancer, advancements in medical imaging technologies, and the growing demand for minimally invasive procedures.

    Hologic, Inc. is a leading player in the Breast Cancer Core Needle Biopsy Market industry. The company offers a comprehensive portfolio of breast biopsy systems and devices, including the Affirm Prone Breast Biopsy System, the Mammotome Revolve Biopsy System, and the ProCore Automated Breast Biopsy System.

    Hologic, Inc. has a strong presence in both the US and international markets and is continuously investing in research and development to enhance its product offerings and expand its market share.

    BD (Becton, Dickinson and Company) is another major player in the Breast Cancer Core Needle Biopsy Market industry. The company offers a wide range of biopsy systems and devices, including the Bard Magnum Core Biopsy Instrument, the Bard Max-Core Biopsy Instrument, and the Bard Precisio Core Biopsy Instrument.

    BD (Becton, Dickinson and Company) has a global presence and is focused on developing innovative technologies and solutions to meet the evolving needs of healthcare professionals and patients.

     

    Key Companies in the Breast Cancer Core Needle Biopsy Market market include

    Industry Developments

    The increasing incidence of breast cancer, technological advancements in biopsy devices, and rising awareness about early detection are key factors driving market growth.

    Recent developments include the launch of automated core needle biopsy systems and AI-powered image analysis software, enhancing accuracy and efficiency. Key players in the market include Becton, Dickinson and Company, Hologic, Inc., and Cook Medical.

     

    Future Outlook

    Breast Cancer Core Needle Biopsy Market Future Outlook

    The Breast Cancer Core Needle Biopsy Market is projected to grow at a 5.05% CAGR from 2024 to 2035, driven by technological advancements, increasing awareness, and rising incidence rates.

    New opportunities lie in:

    • Develop innovative biopsy devices with enhanced precision and minimal invasiveness.
    • Expand telemedicine solutions for remote biopsy consultations and follow-ups.
    • Invest in AI-driven analytics for improved diagnostic accuracy and patient outcomes.

    By 2035, the market is expected to exhibit robust growth, reflecting advancements in technology and increased demand.

    Market Segmentation

    Breast Cancer Core Needle Biopsy Market Modality Outlook

     
    • Outpatient
    • Inpatient

    Breast Cancer Core Needle Biopsy Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia Pacific
    • Middle East and Africa

    Breast Cancer Core Needle Biopsy Market Needle Size Outlook

     
    • Ultrasound-Guided
    • Stereotactic
    • Other

    Breast Cancer Core Needle Biopsy Market Target Tissue Outlook

     
    • 14-Gauge
    • 16-Gauge
    • 18-Gauge
    • 20-Gauge
    • 22-Gauge

    Breast Cancer Core Needle Biopsy Market Procedure Type Outlook

     
    • Vacuum-Assisted
    • Spring-Loaded
    • Gravity-Fed

    Breast Cancer Core Needle Biopsy Market Biopsy Device Type Outlook

     
    • North America
    • Europe
    • South America
    • Asia Pacific
    • Middle East and Africa

    Report Scope

    Report Attribute/Metric Details
    Market Size 2023 0.38(USD Billion)
    Market Size 2024 0.4 (USD Billion)
    Market Size 2032 0.59 (USD Billion)
    Compound Annual Growth Rate (CAGR) 5.25% (2024 - 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2023
    Market Forecast Period 2024 - 2032
    Historical Data 2019 - 2023
    Market Forecast Units USD Billion
    Key Companies Profiled Invivo Medical, BD, AngioDynamics, Hologic, Cook Medical, Carl Zeiss, EndoClot Plus, Argon Medical Devices, C.R. Bard, Medicsight Telemedicine Technology, Cianna Medical, Devicor Medical Products, Olympus, Leica Biosystems, FUJIFILM Holdings
    Segments Covered Target Tissue, Needle Size, Modality, Procedure Type, Biopsy Device Type, Regional
    Key Market Opportunities Rising prevalence of breast cancer Technological advancements in biopsy devices Increasing adoption of minimally invasive procedures Growing demand for early and accurate diagnosis Expansion of healthcare infrastructure in emerging markets
    Key Market Dynamics Increasing breast cancer prevalence Technological advancements Growing adoption of minimally invasive procedures Government initiatives and reimbursement policies Rising demand for accurate and timely diagnosis
    Countries Covered North America, Europe, APAC, South America, MEA

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Get In Touch
    Leave a Comment

    FAQs

    What was the market size of the Global Breast Cancer Core Needle Biopsy Market in 2023?

    The Global Breast Cancer Core Needle Biopsy Market was worth 0.38 billion USD in 2023.

    What is the projected CAGR of the Global Breast Cancer Core Needle Biopsy Market from 2024 to 2032?

    The Global Breast Cancer Core Needle Biopsy Market is projected to grow at a CAGR of 5.25% from 2024 to 2032.

    Which region is expected to dominate the Global Breast Cancer Core Needle Biopsy Market?

    North America is expected to dominate the Global Breast Cancer Core Needle Biopsy Market throughout the forecast period.

    What are the key applications of Breast Cancer Core Needle Biopsy?

    Key applications of Breast Cancer Core Needle Biopsy include diagnostic evaluation of breast masses and lesions, staging of breast cancer, and monitoring response to treatment.

    Who are the key competitors in the Global Breast Cancer Core Needle Biopsy Market?

    Key competitors in the Global Breast Cancer Core Needle Biopsy Market include Becton, Dickinson and Company, Hologic Inc., and C. R. Bard.

    What is the market size of the Global Breast Cancer Core Needle Biopsy Market in the Asia-Pacific region?

    The Asia-Pacific region is expected to reach a market size of 1.2 billion USD by 2032.

    What are the growth drivers of the Global Breast Cancer Core Needle Biopsy Market?

    Growth drivers of the Global Breast Cancer Core Needle Biopsy Market include increasing incidence of breast cancer, rising demand for minimally invasive procedures, and technological advancements.

    What are the challenges faced by the Global Breast Cancer Core Needle Biopsy Market?

    Challenges faced by the Global Breast Cancer Core Needle Biopsy Market include high cost of procedures and reimbursement issues.

    1. EXECUTIVE SUMMARY
      1. Market Overview
      2. Key Findings
      3. Market Segmentation
      4. Competitive Landscape
      5. Challenges and Opportunities
      6. Future Outlook
    2. MARKET INTRODUCTION
      1. Definition
      2. Scope of the study
    3. Research Objective
      1. Assumption
        1. Limitations
    4. RESEARCH
    5. METHODOLOGY
      1. Overview
      2. Data Mining
      3. Secondary Research
      4. Primary Research
        1. Primary Interviews and Information Gathering
    6. Process
      1. Breakdown of Primary Respondents
      2. Forecasting Model
      3. Market Size Estimation
        1. Bottom-Up Approach
        2. Top-Down
    7. Approach
      1. Data Triangulation
      2. Validation
    8. MARKET DYNAMICS
      1. Overview
      2. Drivers
      3. Restraints
      4. Opportunities
    9. MARKET FACTOR ANALYSIS
      1. Value chain Analysis
      2. Porter's Five Forces Analysis
        1. Bargaining Power of Suppliers
        2. Bargaining Power of Buyers
        3. Threat of New Entrants
    10. Threat of Substitutes
      1. Intensity of Rivalry
      2. COVID-19 Impact
    11. Analysis
      1. Market Impact Analysis
        1. Regional Impact
    12. Opportunity and Threat Analysis
    13. BREAST CANCER CORE NEEDLE
    14. BIOPSY MARKET, BY TARGET TISSUE (USD BILLION)
      1. Breast
      2. Prostate
      3. Lung
      4. Liver
      5. Kidney
    15. BREAST CANCER CORE NEEDLE BIOPSY
    16. MARKET, BY NEEDLE SIZE (USD BILLION)
      1. 14-Gauge
      2. 16-Gauge
    17. Gauge
      1. 20-Gauge
      2. 22-Gauge
    18. BREAST CANCER CORE NEEDLE
    19. BIOPSY MARKET, BY MODALITY (USD BILLION)
      1. Ultrasound-Guided
      2. Stereotactic
      3. Other
    20. BREAST CANCER CORE NEEDLE BIOPSY MARKET, BY PROCEDURE TYPE
    21. (USD BILLION)
      1. Outpatient
      2. Inpatient
    22. BREAST CANCER CORE
    23. NEEDLE BIOPSY MARKET, BY BIOPSY DEVICE TYPE (USD BILLION)
      1. Vacuum-Assisted
      2. Spring-Loaded
      3. Gravity-Fed
    24. BREAST CANCER CORE NEEDLE
    25. BIOPSY MARKET, BY REGIONAL (USD BILLION)
      1. North America
        1. US
        2. Canada
      2. Europe
        1. Germany
        2. UK
    26. France
      1. Russia
        1. Italy
        2. Spain
        3. Rest
    27. of Europe
      1. APAC
        1. China
        2. India
        3. Japan
        4. South Korea
        5. Malaysia
        6. Thailand
        7. Indonesia
        8. Rest of APAC
      2. South America
        1. Brazil
    28. Mexico
      1. Argentina
        1. Rest of South America
      2. MEA
        1. GCC Countries
        2. South Africa
        3. Rest of MEA
    29. COMPETITIVE LANDSCAPE
      1. Overview
      2. Competitive
    30. Analysis
      1. Market share Analysis
      2. Major Growth Strategy in the
    31. Breast Cancer Core Needle Biopsy Market
      1. Competitive Benchmarking
    32. Leading Players in Terms of Number of Developments in the Breast Cancer Core Needle
    33. Biopsy Market
      1. Key developments and growth strategies
        1. New
    34. Product Launch/Service Deployment
      1. Merger & Acquisitions
    35. Joint Ventures
      1. Major Players Financial Matrix
        1. Sales and
    36. Operating Income
      1. Major Players R&D Expenditure. 2023
    37. COMPANY
    38. PROFILES
      1. Invivo Medical
        1. Financial Overview
    39. Products Offered
      1. Key Developments
        1. SWOT Analysis
    40. Key Strategies
      1. BD
        1. Financial Overview
        2. Products
    41. Offered
      1. Key Developments
        1. SWOT Analysis
        2. Key
    42. Strategies
      1. AngioDynamics
        1. Financial Overview
    43. Products Offered
      1. Key Developments
        1. SWOT Analysis
    44. Key Strategies
      1. Hologic
        1. Financial Overview
        2. Products
    45. Offered
      1. Key Developments
        1. SWOT Analysis
        2. Key
    46. Strategies
      1. Cook Medical
        1. Financial Overview
    47. Products Offered
      1. Key Developments
        1. SWOT Analysis
    48. Key Strategies
      1. Carl Zeiss
        1. Financial Overview
    49. Products Offered
      1. Key Developments
        1. SWOT Analysis
    50. Key Strategies
      1. EndoClot Plus
        1. Financial Overview
    51. Products Offered
      1. Key Developments
        1. SWOT Analysis
    52. Key Strategies
      1. Argon Medical Devices
        1. Financial Overview
        2. Products Offered
        3. Key Developments
        4. SWOT Analysis
        5. Key Strategies
      2. C.R. Bard
        1. Financial Overview
        2. Products Offered
        3. Key Developments
        4. SWOT Analysis
        5. Key Strategies
      3. Medicsight Telemedicine Technology
    53. Financial Overview
      1. Products Offered
        1. Key Developments
        2. SWOT Analysis
        3. Key Strategies
      2. Cianna Medical
        1. Financial Overview
        2. Products Offered
        3. Key Developments
        4. SWOT Analysis
        5. Key Strategies
      3. Devicor Medical
    54. Products
      1. Financial Overview
        1. Products Offered
    55. Key Developments
      1. SWOT Analysis
        1. Key Strategies
    56. Olympus
      1. Financial Overview
        1. Products Offered
    57. Key Developments
      1. SWOT Analysis
        1. Key Strategies
    58. Leica Biosystems
      1. Financial Overview
        1. Products Offered
        2. Key Developments
        3. SWOT Analysis
        4. Key Strategies
      2. FUJIFILM Holdings
        1. Financial Overview
        2. Products
    59. Offered
      1. Key Developments
        1. SWOT Analysis
    60. Key Strategies
    61. APPENDIX
      1. References
      2. Related Reports
    62. BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY TARGET
    63. TISSUE, 2019-2032 (USD BILLIONS)
    64. NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY NEEDLE SIZE, 2019-2032 (USD
    65. BILLIONS)
    66. ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
    67. AMERICA BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY
    68. PROCEDURE TYPE, 2019-2032 (USD BILLIONS)
    69. CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY BIOPSY DEVICE TYPE,
    70. 2032 (USD BILLIONS)
    71. MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
    72. US BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY
    73. TARGET TISSUE, 2019-2032 (USD BILLIONS)
    74. BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY NEEDLE SIZE, 2019-2032 (USD BILLIONS)
    75. BY MODALITY, 2019-2032 (USD BILLIONS)
    76. BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY PROCEDURE TYPE, 2019-2032 (USD BILLIONS)
    77. BY BIOPSY DEVICE TYPE, 2019-2032 (USD BILLIONS)
    78. CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032
    79. (USD BILLIONS)
    80. ESTIMATES & FORECAST, BY TARGET TISSUE, 2019-2032 (USD BILLIONS)
    81. CANADA BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST,
    82. BY NEEDLE SIZE, 2019-2032 (USD BILLIONS)
    83. NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD
    84. BILLIONS)
    85. & FORECAST, BY PROCEDURE TYPE, 2019-2032 (USD BILLIONS)
    86. BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY BIOPSY
    87. DEVICE TYPE, 2019-2032 (USD BILLIONS)
    88. BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
    89. FORECAST, BY TARGET TISSUE, 2019-2032 (USD BILLIONS)
    90. CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY NEEDLE SIZE,
    91. 2032 (USD BILLIONS)
    92. MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
    93. EUROPE BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST,
    94. BY PROCEDURE TYPE, 2019-2032 (USD BILLIONS)
    95. CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY BIOPSY DEVICE TYPE,
    96. 2032 (USD BILLIONS)
    97. MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
    98. GERMANY BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST,
    99. BY TARGET TISSUE, 2019-2032 (USD BILLIONS)
    100. CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY NEEDLE SIZE, 2019-2032
    101. (USD BILLIONS)
    102. ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
    103. BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY PROCEDURE
    104. TYPE, 2019-2032 (USD BILLIONS)
    105. BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY BIOPSY DEVICE TYPE, 2019-2032 (USD
    106. BILLIONS)
    107. & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
    108. CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY TARGET TISSUE, 2019-2032
    109. (USD BILLIONS)
    110. & FORECAST, BY NEEDLE SIZE, 2019-2032 (USD BILLIONS)
    111. CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032
    112. (USD BILLIONS)
    113. & FORECAST, BY PROCEDURE TYPE, 2019-2032 (USD BILLIONS)
    114. CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY BIOPSY DEVICE
    115. TYPE, 2019-2032 (USD BILLIONS)
    116. MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
    117. FRANCE BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST,
    118. BY TARGET TISSUE, 2019-2032 (USD BILLIONS)
    119. NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY NEEDLE SIZE, 2019-2032 (USD
    120. BILLIONS)
    121. & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
    122. CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY PROCEDURE TYPE,
    123. 2032 (USD BILLIONS)
    124. MARKET SIZE ESTIMATES & FORECAST, BY BIOPSY DEVICE TYPE, 2019-2032 (USD BILLIONS)
    125. FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
    126. CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY TARGET TISSUE, 2019-2032
    127. (USD BILLIONS)
    128. ESTIMATES & FORECAST, BY NEEDLE SIZE, 2019-2032 (USD BILLIONS)
    129. RUSSIA BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY
    130. MODALITY, 2019-2032 (USD BILLIONS)
    131. BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY PROCEDURE TYPE, 2019-2032 (USD BILLIONS)
    132. FORECAST, BY BIOPSY DEVICE TYPE, 2019-2032 (USD BILLIONS)
    133. BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL,
    134. 2032 (USD BILLIONS)
    135. SIZE ESTIMATES & FORECAST, BY TARGET TISSUE, 2019-2032 (USD BILLIONS)
    136. ITALY BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST,
    137. BY NEEDLE SIZE, 2019-2032 (USD BILLIONS)
    138. NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD
    139. BILLIONS)
    140. & FORECAST, BY PROCEDURE TYPE, 2019-2032 (USD BILLIONS)
    141. BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY BIOPSY
    142. DEVICE TYPE, 2019-2032 (USD BILLIONS)
    143. BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
    144. BY TARGET TISSUE, 2019-2032 (USD BILLIONS)
    145. NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY NEEDLE SIZE, 2019-2032 (USD
    146. BILLIONS)
    147. & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
    148. CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY PROCEDURE TYPE,
    149. 2032 (USD BILLIONS)
    150. SIZE ESTIMATES & FORECAST, BY BIOPSY DEVICE TYPE, 2019-2032 (USD BILLIONS)
    151. BY REGIONAL, 2019-2032 (USD BILLIONS)
    152. CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY TARGET TISSUE, 2019-2032
    153. (USD BILLIONS)
    154. SIZE ESTIMATES & FORECAST, BY NEEDLE SIZE, 2019-2032 (USD BILLIONS)
    155. REST OF EUROPE BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES &
    156. FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
    157. CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY PROCEDURE TYPE,
    158. 2032 (USD BILLIONS)
    159. BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY BIOPSY DEVICE TYPE, 2019-2032 (USD
    160. BILLIONS)
    161. SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
    162. APAC BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST,
    163. BY TARGET TISSUE, 2019-2032 (USD BILLIONS)
    164. NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY NEEDLE SIZE, 2019-2032 (USD
    165. BILLIONS)
    166. & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
    167. CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY PROCEDURE TYPE,
    168. 2032 (USD BILLIONS)
    169. SIZE ESTIMATES & FORECAST, BY BIOPSY DEVICE TYPE, 2019-2032 (USD BILLIONS)
    170. BY REGIONAL, 2019-2032 (USD BILLIONS)
    171. BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY TARGET TISSUE, 2019-2032 (USD BILLIONS)
    172. BY NEEDLE SIZE, 2019-2032 (USD BILLIONS)
    173. NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD
    174. BILLIONS)
    175. & FORECAST, BY PROCEDURE TYPE, 2019-2032 (USD BILLIONS)
    176. BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY BIOPSY
    177. DEVICE TYPE, 2019-2032 (USD BILLIONS)
    178. BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
    179. BY TARGET TISSUE, 2019-2032 (USD BILLIONS)
    180. NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY NEEDLE SIZE, 2019-2032 (USD
    181. BILLIONS)
    182. & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
    183. CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY PROCEDURE TYPE,
    184. 2032 (USD BILLIONS)
    185. SIZE ESTIMATES & FORECAST, BY BIOPSY DEVICE TYPE, 2019-2032 (USD BILLIONS)
    186. BY REGIONAL, 2019-2032 (USD BILLIONS)
    187. BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY TARGET TISSUE, 2019-2032 (USD BILLIONS)
    188. BY NEEDLE SIZE, 2019-2032 (USD BILLIONS)
    189. NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD
    190. BILLIONS)
    191. & FORECAST, BY PROCEDURE TYPE, 2019-2032 (USD BILLIONS)
    192. BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY BIOPSY
    193. DEVICE TYPE, 2019-2032 (USD BILLIONS)
    194. BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
    195. FORECAST, BY TARGET TISSUE, 2019-2032 (USD BILLIONS)
    196. BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY NEEDLE
    197. SIZE, 2019-2032 (USD BILLIONS)
    198. BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
    199. FORECAST, BY PROCEDURE TYPE, 2019-2032 (USD BILLIONS)
    200. BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY BIOPSY
    201. DEVICE TYPE, 2019-2032 (USD BILLIONS)
    202. NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD
    203. BILLIONS)
    204. & FORECAST, BY TARGET TISSUE, 2019-2032 (USD BILLIONS)
    205. BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY NEEDLE
    206. SIZE, 2019-2032 (USD BILLIONS)
    207. BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
    208. FORECAST, BY PROCEDURE TYPE, 2019-2032 (USD BILLIONS)
    209. CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY BIOPSY DEVICE
    210. TYPE, 2019-2032 (USD BILLIONS)
    211. BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
    212. FORECAST, BY TARGET TISSUE, 2019-2032 (USD BILLIONS)
    213. CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY NEEDLE SIZE,
    214. 2032 (USD BILLIONS)
    215. MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
    216. THAILAND BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST,
    217. BY PROCEDURE TYPE, 2019-2032 (USD BILLIONS)
    218. CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY BIOPSY DEVICE TYPE,
    219. 2032 (USD BILLIONS)
    220. MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
    221. INDONESIA BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST,
    222. BY TARGET TISSUE, 2019-2032 (USD BILLIONS)
    223. CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY NEEDLE SIZE, 2019-2032
    224. (USD BILLIONS)
    225. SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
    226. INDONESIA BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST,
    227. BY PROCEDURE TYPE, 2019-2032 (USD BILLIONS)
    228. CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY BIOPSY DEVICE TYPE,
    229. 2032 (USD BILLIONS)
    230. MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
    231. REST OF APAC BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST,
    232. BY TARGET TISSUE, 2019-2032 (USD BILLIONS)
    233. CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY NEEDLE SIZE, 2019-2032
    234. (USD BILLIONS)
    235. SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
    236. REST OF APAC BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST,
    237. BY PROCEDURE TYPE, 2019-2032 (USD BILLIONS)
    238. CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY BIOPSY DEVICE
    239. TYPE, 2019-2032 (USD BILLIONS)
    240. BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
    241. & FORECAST, BY TARGET TISSUE, 2019-2032 (USD BILLIONS)
    242. AMERICA BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY
    243. NEEDLE SIZE, 2019-2032 (USD BILLIONS)
    244. CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032
    245. (USD BILLIONS)
    246. SIZE ESTIMATES & FORECAST, BY PROCEDURE TYPE, 2019-2032 (USD BILLIONS)
    247. SOUTH AMERICA BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES &
    248. FORECAST, BY BIOPSY DEVICE TYPE, 2019-2032 (USD BILLIONS)
    249. AMERICA BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY
    250. REGIONAL, 2019-2032 (USD BILLIONS)
    251. BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY TARGET TISSUE, 2019-2032 (USD BILLIONS)
    252. FORECAST, BY NEEDLE SIZE, 2019-2032 (USD BILLIONS)
    253. CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032
    254. (USD BILLIONS)
    255. ESTIMATES & FORECAST, BY PROCEDURE TYPE, 2019-2032 (USD BILLIONS)
    256. BRAZIL BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST,
    257. BY BIOPSY DEVICE TYPE, 2019-2032 (USD BILLIONS)
    258. CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032
    259. (USD BILLIONS)
    260. ESTIMATES & FORECAST, BY TARGET TISSUE, 2019-2032 (USD BILLIONS)
    261. MEXICO BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST,
    262. BY NEEDLE SIZE, 2019-2032 (USD BILLIONS)
    263. NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD
    264. BILLIONS)
    265. & FORECAST, BY PROCEDURE TYPE, 2019-2032 (USD BILLIONS)
    266. BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY BIOPSY
    267. DEVICE TYPE, 2019-2032 (USD BILLIONS)
    268. NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD
    269. BILLIONS)
    270. ESTIMATES & FORECAST, BY TARGET TISSUE, 2019-2032 (USD BILLIONS)
    271. ARGENTINA BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST,
    272. BY NEEDLE SIZE, 2019-2032 (USD BILLIONS)
    273. CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032
    274. (USD BILLIONS)
    275. SIZE ESTIMATES & FORECAST, BY PROCEDURE TYPE, 2019-2032 (USD BILLIONS)
    276. ARGENTINA BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST,
    277. BY BIOPSY DEVICE TYPE, 2019-2032 (USD BILLIONS)
    278. CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032
    279. (USD BILLIONS)
    280. MARKET SIZE ESTIMATES & FORECAST, BY TARGET TISSUE, 2019-2032 (USD BILLIONS)
    281. ESTIMATES & FORECAST, BY NEEDLE SIZE, 2019-2032 (USD BILLIONS)
    282. REST OF SOUTH AMERICA BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES &
    283. FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
    284. BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY PROCEDURE
    285. TYPE, 2019-2032 (USD BILLIONS)
    286. CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY BIOPSY DEVICE TYPE,
    287. 2032 (USD BILLIONS)
    288. NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD
    289. BILLIONS)
    290. & FORECAST, BY TARGET TISSUE, 2019-2032 (USD BILLIONS)
    291. CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY NEEDLE SIZE,
    292. 2032 (USD BILLIONS)
    293. SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
    294. MEA BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST,
    295. BY PROCEDURE TYPE, 2019-2032 (USD BILLIONS)
    296. NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY BIOPSY DEVICE TYPE, 2019-2032
    297. (USD BILLIONS)
    298. ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
    299. GCC COUNTRIES BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST,
    300. BY TARGET TISSUE, 2019-2032 (USD BILLIONS)
    301. CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY NEEDLE SIZE,
    302. 2032 (USD BILLIONS)
    303. BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
    304. & FORECAST, BY PROCEDURE TYPE, 2019-2032 (USD BILLIONS)
    305. COUNTRIES BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST,
    306. BY BIOPSY DEVICE TYPE, 2019-2032 (USD BILLIONS)
    307. CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032
    308. (USD BILLIONS)
    309. SIZE ESTIMATES & FORECAST, BY TARGET TISSUE, 2019-2032 (USD BILLIONS)
    310. SOUTH AFRICA BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST,
    311. BY NEEDLE SIZE, 2019-2032 (USD BILLIONS)
    312. CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032
    313. (USD BILLIONS)
    314. SIZE ESTIMATES & FORECAST, BY PROCEDURE TYPE, 2019-2032 (USD BILLIONS)
    315. SOUTH AFRICA BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST,
    316. BY BIOPSY DEVICE TYPE, 2019-2032 (USD BILLIONS)
    317. CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032
    318. (USD BILLIONS)
    319. SIZE ESTIMATES & FORECAST, BY TARGET TISSUE, 2019-2032 (USD BILLIONS)
    320. REST OF MEA BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST,
    321. BY NEEDLE SIZE, 2019-2032 (USD BILLIONS)
    322. CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032
    323. (USD BILLIONS)
    324. SIZE ESTIMATES & FORECAST, BY PROCEDURE TYPE, 2019-2032 (USD BILLIONS)
    325. REST OF MEA BREAST CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST,
    326. BY BIOPSY DEVICE TYPE, 2019-2032 (USD BILLIONS)
    327. CANCER CORE NEEDLE BIOPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032
    328. (USD BILLIONS)
    329. ACQUISITION/PARTNERSHIP
    330. MARKET SYNOPSIS
    331. ANALYSIS
    332. TISSUE
    333. SIZE
    334. TYPE
    335. TYPE
    336. BIOPSY DEVICE TYPE
    337. ANALYSIS BY REGIONAL
    338. ANALYSIS
    339. BY TARGET TISSUE
    340. ANALYSIS BY NEEDLE SIZE
    341. MARKET ANALYSIS BY MODALITY
    342. MARKET ANALYSIS BY PROCEDURE TYPE
    343. BIOPSY MARKET ANALYSIS BY BIOPSY DEVICE TYPE
    344. CORE NEEDLE BIOPSY MARKET ANALYSIS BY REGIONAL
    345. CORE NEEDLE BIOPSY MARKET ANALYSIS BY TARGET TISSUE
    346. CORE NEEDLE BIOPSY MARKET ANALYSIS BY NEEDLE SIZE
    347. CORE NEEDLE BIOPSY MARKET ANALYSIS BY MODALITY
    348. CORE NEEDLE BIOPSY MARKET ANALYSIS BY PROCEDURE TYPE
    349. CORE NEEDLE BIOPSY MARKET ANALYSIS BY BIOPSY DEVICE TYPE
    350. CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY REGIONAL
    351. CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY TARGET TISSUE
    352. BREAST CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY NEEDLE SIZE
    353. FRANCE BREAST CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY MODALITY
    354. FRANCE BREAST CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY PROCEDURE TYPE
    355. TYPE
    356. REGIONAL
    357. BY TARGET TISSUE
    358. ANALYSIS BY NEEDLE SIZE
    359. MARKET ANALYSIS BY MODALITY
    360. MARKET ANALYSIS BY PROCEDURE TYPE
    361. BIOPSY MARKET ANALYSIS BY BIOPSY DEVICE TYPE
    362. CORE NEEDLE BIOPSY MARKET ANALYSIS BY REGIONAL
    363. CORE NEEDLE BIOPSY MARKET ANALYSIS BY TARGET TISSUE
    364. CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY NEEDLE SIZE
    365. CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY MODALITY
    366. CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY PROCEDURE TYPE
    367. BREAST CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY BIOPSY DEVICE TYPE
    368. ITALY BREAST CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY REGIONAL
    369. SPAIN BREAST CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY TARGET TISSUE
    370. SPAIN BREAST CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY NEEDLE SIZE
    371. SPAIN BREAST CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY MODALITY
    372. SPAIN BREAST CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY PROCEDURE TYPE
    373. TYPE
    374. TARGET TISSUE
    375. ANALYSIS BY NEEDLE SIZE
    376. BIOPSY MARKET ANALYSIS BY MODALITY
    377. CORE NEEDLE BIOPSY MARKET ANALYSIS BY PROCEDURE TYPE
    378. BREAST CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY BIOPSY DEVICE TYPE
    379. REST OF EUROPE BREAST CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY REGIONAL
    380. CHINA BREAST CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY TARGET TISSUE
    381. CHINA BREAST CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY NEEDLE SIZE
    382. CHINA BREAST CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY MODALITY
    383. CHINA BREAST CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY PROCEDURE TYPE
    384. TYPE
    385. TYPE
    386. DEVICE TYPE
    387. BY REGIONAL
    388. BY TARGET TISSUE
    389. BY NEEDLE SIZE
    390. BY MODALITY
    391. BY PROCEDURE TYPE
    392. ANALYSIS BY BIOPSY DEVICE TYPE
    393. MARKET ANALYSIS BY REGIONAL
    394. BIOPSY MARKET ANALYSIS BY TARGET TISSUE
    395. CORE NEEDLE BIOPSY MARKET ANALYSIS BY NEEDLE SIZE
    396. CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY MODALITY
    397. BREAST CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY PROCEDURE TYPE
    398. SOUTH KOREA BREAST CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY BIOPSY DEVICE TYPE
    399. TISSUE
    400. BY NEEDLE SIZE
    401. ANALYSIS BY MODALITY
    402. ANALYSIS BY PROCEDURE TYPE
    403. MARKET ANALYSIS BY BIOPSY DEVICE TYPE
    404. NEEDLE BIOPSY MARKET ANALYSIS BY REGIONAL
    405. CORE NEEDLE BIOPSY MARKET ANALYSIS BY TARGET TISSUE
    406. CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY NEEDLE SIZE
    407. BREAST CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY MODALITY
    408. BREAST CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY PROCEDURE TYPE
    409. THAILAND BREAST CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY BIOPSY DEVICE TYPE
    410. TISSUE
    411. BY NEEDLE SIZE
    412. ANALYSIS BY MODALITY
    413. MARKET ANALYSIS BY PROCEDURE TYPE
    414. BIOPSY MARKET ANALYSIS BY BIOPSY DEVICE TYPE
    415. CORE NEEDLE BIOPSY MARKET ANALYSIS BY REGIONAL
    416. CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY TARGET TISSUE
    417. OF APAC BREAST CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY NEEDLE SIZE
    418. REST OF APAC BREAST CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY MODALITY
    419. TYPE
    420. BY BIOPSY DEVICE TYPE
    421. MARKET ANALYSIS BY REGIONAL
    422. BIOPSY MARKET ANALYSIS
    423. MARKET ANALYSIS BY TARGET TISSUE
    424. BIOPSY MARKET ANALYSIS BY NEEDLE SIZE
    425. NEEDLE BIOPSY MARKET ANALYSIS BY MODALITY
    426. CORE NEEDLE BIOPSY MARKET ANALYSIS BY PROCEDURE TYPE
    427. CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY BIOPSY DEVICE TYPE
    428. BRAZIL BREAST CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY REGIONAL
    429. MEXICO BREAST CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY TARGET TISSUE
    430. SIZE
    431. MODALITY
    432. BY PROCEDURE TYPE
    433. ANALYSIS BY BIOPSY DEVICE TYPE
    434. BIOPSY MARKET ANALYSIS BY REGIONAL
    435. NEEDLE BIOPSY MARKET ANALYSIS BY TARGET TISSUE
    436. CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY NEEDLE SIZE
    437. BREAST CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY MODALITY
    438. BREAST CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY PROCEDURE TYPE
    439. ARGENTINA BREAST CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY BIOPSY DEVICE TYPE
    440. BY TARGET TISSUE
    441. BIOPSY MARKET ANALYSIS BY NEEDLE SIZE
    442. CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY MODALITY
    443. AMERICA BREAST CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY PROCEDURE TYPE
    444. REST OF SOUTH AMERICA BREAST CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY BIOPSY
    445. DEVICE TYPE
    446. MARKET ANALYSIS BY REGIONAL
    447. MARKET ANALYSIS
    448. MARKET ANALYSIS BY TARGET TISSUE
    449. NEEDLE BIOPSY MARKET ANALYSIS BY NEEDLE SIZE
    450. CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY MODALITY
    451. BREAST CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY PROCEDURE TYPE
    452. GCC COUNTRIES BREAST CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY BIOPSY DEVICE
    453. TYPE
    454. BY REGIONAL
    455. ANALYSIS BY TARGET TISSUE
    456. BIOPSY MARKET ANALYSIS BY NEEDLE SIZE
    457. CORE NEEDLE BIOPSY MARKET ANALYSIS BY MODALITY
    458. CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY PROCEDURE TYPE
    459. AFRICA BREAST CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY BIOPSY DEVICE TYPE
    460. TISSUE
    461. BY NEEDLE SIZE
    462. ANALYSIS BY MODALITY
    463. MARKET ANALYSIS BY PROCEDURE TYPE
    464. NEEDLE BIOPSY MARKET ANALYSIS BY BIOPSY DEVICE TYPE
    465. BREAST CANCER CORE NEEDLE BIOPSY MARKET ANALYSIS BY REGIONAL
    466. BUYING CRITERIA OF BREAST CANCER CORE NEEDLE BIOPSY MARKET
    467. PROCESS OF MRFR
    468. MARKET
    469. MARKET
    470. MARKET
    471. SHARE)
    472. TO 2032 (USD Billions)
    473. BY NEEDLE SIZE, 2024 (% SHARE)
    474. MARKET, BY NEEDLE SIZE, 2019 TO 2032 (USD Billions)
    475. CORE NEEDLE BIOPSY MARKET, BY MODALITY, 2024 (% SHARE)
    476. CORE NEEDLE BIOPSY MARKET, BY MODALITY, 2019 TO 2032 (USD Billions)
    477. BREAST CANCER CORE NEEDLE BIOPSY MARKET, BY PROCEDURE TYPE, 2024 (% SHARE)
    478. (USD Billions)
    479. BIOPSY DEVICE TYPE, 2024 (% SHARE)
    480. MARKET, BY BIOPSY DEVICE TYPE, 2019 TO 2032 (USD Billions)
    481. CANCER CORE NEEDLE BIOPSY MARKET, BY REGIONAL, 2024 (% SHARE)
    482. CANCER CORE NEEDLE BIOPSY MARKET, BY REGIONAL, 2019 TO 2032 (USD Billions)
    483. BENCHMARKING OF MAJOR COMPETITORS

    Breast Cancer Core Needle Biopsy Market Segmentation

    • Breast Cancer Core Needle Biopsy Market By Target Tissue (USD Billion, 2019-2032)

      • Breast
      • Prostate
      • Lung
      • Liver
      • Kidney

    • Breast Cancer Core Needle Biopsy Market By Needle Size (USD Billion, 2019-2032)

      • 14-Gauge
      • 16-Gauge
      • 18-Gauge
      • 20-Gauge
      • 22-Gauge

    • Breast Cancer Core Needle Biopsy Market By Modality (USD Billion, 2019-2032)

      • Ultrasound-Guided
      • Stereotactic
      • Other

    • Breast Cancer Core Needle Biopsy Market By Procedure Type (USD Billion, 2019-2032)

      • Outpatient
      • Inpatient

    • Breast Cancer Core Needle Biopsy Market By Biopsy Device Type (USD Billion, 2019-2032)

      • Vacuum-Assisted
      • Spring-Loaded
      • Gravity-Fed

    • Breast Cancer Core Needle Biopsy Market By Regional (USD Billion, 2019-2032)

      • North America
      • Europe
      • South America
      • Asia Pacific
      • Middle East and Africa

    Breast Cancer Core Needle Biopsy Market Regional Outlook (USD Billion, 2019-2032)

    • North America Outlook (USD Billion, 2019-2032)

      • North America Breast Cancer Core Needle Biopsy Market by Target Tissue Type

        • Breast
        • Prostate
        • Lung
        • Liver
        • Kidney

      • North America Breast Cancer Core Needle Biopsy Market by Needle Size Type

        • 14-Gauge
        • 16-Gauge
        • 18-Gauge
        • 20-Gauge
        • 22-Gauge

      • North America Breast Cancer Core Needle Biopsy Market by Modality Type

        • Ultrasound-Guided
        • Stereotactic
        • Other

      • North America Breast Cancer Core Needle Biopsy Market by Procedure Type

        • Outpatient
        • Inpatient

      • North America Breast Cancer Core Needle Biopsy Market by Biopsy Device Type

        • Vacuum-Assisted
        • Spring-Loaded
        • Gravity-Fed

      • North America Breast Cancer Core Needle Biopsy Market by Regional Type

        • US
        • Canada
      • US Outlook (USD Billion, 2019-2032)

      • US Breast Cancer Core Needle Biopsy Market by Target Tissue Type

        • Breast
        • Prostate
        • Lung
        • Liver
        • Kidney

      • US Breast Cancer Core Needle Biopsy Market by Needle Size Type

        • 14-Gauge
        • 16-Gauge
        • 18-Gauge
        • 20-Gauge
        • 22-Gauge

      • US Breast Cancer Core Needle Biopsy Market by Modality Type

        • Ultrasound-Guided
        • Stereotactic
        • Other

      • US Breast Cancer Core Needle Biopsy Market by Procedure Type

        • Outpatient
        • Inpatient

      • US Breast Cancer Core Needle Biopsy Market by Biopsy Device Type

        • Vacuum-Assisted
        • Spring-Loaded
        • Gravity-Fed
      • CANADA Outlook (USD Billion, 2019-2032)

      • CANADA Breast Cancer Core Needle Biopsy Market by Target Tissue Type

        • Breast
        • Prostate
        • Lung
        • Liver
        • Kidney

      • CANADA Breast Cancer Core Needle Biopsy Market by Needle Size Type

        • 14-Gauge
        • 16-Gauge
        • 18-Gauge
        • 20-Gauge
        • 22-Gauge

      • CANADA Breast Cancer Core Needle Biopsy Market by Modality Type

        • Ultrasound-Guided
        • Stereotactic
        • Other

      • CANADA Breast Cancer Core Needle Biopsy Market by Procedure Type

        • Outpatient
        • Inpatient

      • CANADA Breast Cancer Core Needle Biopsy Market by Biopsy Device Type

        • Vacuum-Assisted
        • Spring-Loaded
        • Gravity-Fed

    • Europe Outlook (USD Billion, 2019-2032)

      • Europe Breast Cancer Core Needle Biopsy Market by Target Tissue Type

        • Breast
        • Prostate
        • Lung
        • Liver
        • Kidney

      • Europe Breast Cancer Core Needle Biopsy Market by Needle Size Type

        • 14-Gauge
        • 16-Gauge
        • 18-Gauge
        • 20-Gauge
        • 22-Gauge

      • Europe Breast Cancer Core Needle Biopsy Market by Modality Type

        • Ultrasound-Guided
        • Stereotactic
        • Other

      • Europe Breast Cancer Core Needle Biopsy Market by Procedure Type

        • Outpatient
        • Inpatient

      • Europe Breast Cancer Core Needle Biopsy Market by Biopsy Device Type

        • Vacuum-Assisted
        • Spring-Loaded
        • Gravity-Fed

      • Europe Breast Cancer Core Needle Biopsy Market by Regional Type

        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Spain
        • Rest of Europe
      • GERMANY Outlook (USD Billion, 2019-2032)

      • GERMANY Breast Cancer Core Needle Biopsy Market by Target Tissue Type

        • Breast
        • Prostate
        • Lung
        • Liver
        • Kidney

      • GERMANY Breast Cancer Core Needle Biopsy Market by Needle Size Type

        • 14-Gauge
        • 16-Gauge
        • 18-Gauge
        • 20-Gauge
        • 22-Gauge

      • GERMANY Breast Cancer Core Needle Biopsy Market by Modality Type

        • Ultrasound-Guided
        • Stereotactic
        • Other

      • GERMANY Breast Cancer Core Needle Biopsy Market by Procedure Type

        • Outpatient
        • Inpatient

      • GERMANY Breast Cancer Core Needle Biopsy Market by Biopsy Device Type

        • Vacuum-Assisted
        • Spring-Loaded
        • Gravity-Fed
      • UK Outlook (USD Billion, 2019-2032)

      • UK Breast Cancer Core Needle Biopsy Market by Target Tissue Type

        • Breast
        • Prostate
        • Lung
        • Liver
        • Kidney

      • UK Breast Cancer Core Needle Biopsy Market by Needle Size Type

        • 14-Gauge
        • 16-Gauge
        • 18-Gauge
        • 20-Gauge
        • 22-Gauge

      • UK Breast Cancer Core Needle Biopsy Market by Modality Type

        • Ultrasound-Guided
        • Stereotactic
        • Other

      • UK Breast Cancer Core Needle Biopsy Market by Procedure Type

        • Outpatient
        • Inpatient

      • UK Breast Cancer Core Needle Biopsy Market by Biopsy Device Type

        • Vacuum-Assisted
        • Spring-Loaded
        • Gravity-Fed
      • FRANCE Outlook (USD Billion, 2019-2032)

      • FRANCE Breast Cancer Core Needle Biopsy Market by Target Tissue Type

        • Breast
        • Prostate
        • Lung
        • Liver
        • Kidney

      • FRANCE Breast Cancer Core Needle Biopsy Market by Needle Size Type

        • 14-Gauge
        • 16-Gauge
        • 18-Gauge
        • 20-Gauge
        • 22-Gauge

      • FRANCE Breast Cancer Core Needle Biopsy Market by Modality Type

        • Ultrasound-Guided
        • Stereotactic
        • Other

      • FRANCE Breast Cancer Core Needle Biopsy Market by Procedure Type

        • Outpatient
        • Inpatient

      • FRANCE Breast Cancer Core Needle Biopsy Market by Biopsy Device Type

        • Vacuum-Assisted
        • Spring-Loaded
        • Gravity-Fed
      • RUSSIA Outlook (USD Billion, 2019-2032)

      • RUSSIA Breast Cancer Core Needle Biopsy Market by Target Tissue Type

        • Breast
        • Prostate
        • Lung
        • Liver
        • Kidney

      • RUSSIA Breast Cancer Core Needle Biopsy Market by Needle Size Type

        • 14-Gauge
        • 16-Gauge
        • 18-Gauge
        • 20-Gauge
        • 22-Gauge

      • RUSSIA Breast Cancer Core Needle Biopsy Market by Modality Type

        • Ultrasound-Guided
        • Stereotactic
        • Other

      • RUSSIA Breast Cancer Core Needle Biopsy Market by Procedure Type

        • Outpatient
        • Inpatient

      • RUSSIA Breast Cancer Core Needle Biopsy Market by Biopsy Device Type

        • Vacuum-Assisted
        • Spring-Loaded
        • Gravity-Fed
      • ITALY Outlook (USD Billion, 2019-2032)

      • ITALY Breast Cancer Core Needle Biopsy Market by Target Tissue Type

        • Breast
        • Prostate
        • Lung
        • Liver
        • Kidney

      • ITALY Breast Cancer Core Needle Biopsy Market by Needle Size Type

        • 14-Gauge
        • 16-Gauge
        • 18-Gauge
        • 20-Gauge
        • 22-Gauge

      • ITALY Breast Cancer Core Needle Biopsy Market by Modality Type

        • Ultrasound-Guided
        • Stereotactic
        • Other

      • ITALY Breast Cancer Core Needle Biopsy Market by Procedure Type

        • Outpatient
        • Inpatient

      • ITALY Breast Cancer Core Needle Biopsy Market by Biopsy Device Type

        • Vacuum-Assisted
        • Spring-Loaded
        • Gravity-Fed
      • SPAIN Outlook (USD Billion, 2019-2032)

      • SPAIN Breast Cancer Core Needle Biopsy Market by Target Tissue Type

        • Breast
        • Prostate
        • Lung
        • Liver
        • Kidney

      • SPAIN Breast Cancer Core Needle Biopsy Market by Needle Size Type

        • 14-Gauge
        • 16-Gauge
        • 18-Gauge
        • 20-Gauge
        • 22-Gauge

      • SPAIN Breast Cancer Core Needle Biopsy Market by Modality Type

        • Ultrasound-Guided
        • Stereotactic
        • Other

      • SPAIN Breast Cancer Core Needle Biopsy Market by Procedure Type

        • Outpatient
        • Inpatient

      • SPAIN Breast Cancer Core Needle Biopsy Market by Biopsy Device Type

        • Vacuum-Assisted
        • Spring-Loaded
        • Gravity-Fed
      • REST OF EUROPE Outlook (USD Billion, 2019-2032)

      • REST OF EUROPE Breast Cancer Core Needle Biopsy Market by Target Tissue Type

        • Breast
        • Prostate
        • Lung
        • Liver
        • Kidney

      • REST OF EUROPE Breast Cancer Core Needle Biopsy Market by Needle Size Type

        • 14-Gauge
        • 16-Gauge
        • 18-Gauge
        • 20-Gauge
        • 22-Gauge

      • REST OF EUROPE Breast Cancer Core Needle Biopsy Market by Modality Type

        • Ultrasound-Guided
        • Stereotactic
        • Other

      • REST OF EUROPE Breast Cancer Core Needle Biopsy Market by Procedure Type

        • Outpatient
        • Inpatient

      • REST OF EUROPE Breast Cancer Core Needle Biopsy Market by Biopsy Device Type

        • Vacuum-Assisted
        • Spring-Loaded
        • Gravity-Fed

    • APAC Outlook (USD Billion, 2019-2032)

      • APAC Breast Cancer Core Needle Biopsy Market by Target Tissue Type

        • Breast
        • Prostate
        • Lung
        • Liver
        • Kidney

      • APAC Breast Cancer Core Needle Biopsy Market by Needle Size Type

        • 14-Gauge
        • 16-Gauge
        • 18-Gauge
        • 20-Gauge
        • 22-Gauge

      • APAC Breast Cancer Core Needle Biopsy Market by Modality Type

        • Ultrasound-Guided
        • Stereotactic
        • Other

      • APAC Breast Cancer Core Needle Biopsy Market by Procedure Type

        • Outpatient
        • Inpatient

      • APAC Breast Cancer Core Needle Biopsy Market by Biopsy Device Type

        • Vacuum-Assisted
        • Spring-Loaded
        • Gravity-Fed

      • APAC Breast Cancer Core Needle Biopsy Market by Regional Type

        • China
        • India
        • Japan
        • South Korea
        • Malaysia
        • Thailand
        • Indonesia
        • Rest of APAC
      • CHINA Outlook (USD Billion, 2019-2032)

      • CHINA Breast Cancer Core Needle Biopsy Market by Target Tissue Type

        • Breast
        • Prostate
        • Lung
        • Liver
        • Kidney

      • CHINA Breast Cancer Core Needle Biopsy Market by Needle Size Type

        • 14-Gauge
        • 16-Gauge
        • 18-Gauge
        • 20-Gauge
        • 22-Gauge

      • CHINA Breast Cancer Core Needle Biopsy Market by Modality Type

        • Ultrasound-Guided
        • Stereotactic
        • Other

      • CHINA Breast Cancer Core Needle Biopsy Market by Procedure Type

        • Outpatient
        • Inpatient

      • CHINA Breast Cancer Core Needle Biopsy Market by Biopsy Device Type

        • Vacuum-Assisted
        • Spring-Loaded
        • Gravity-Fed
      • INDIA Outlook (USD Billion, 2019-2032)

      • INDIA Breast Cancer Core Needle Biopsy Market by Target Tissue Type

        • Breast
        • Prostate
        • Lung
        • Liver
        • Kidney

      • INDIA Breast Cancer Core Needle Biopsy Market by Needle Size Type

        • 14-Gauge
        • 16-Gauge
        • 18-Gauge
        • 20-Gauge
        • 22-Gauge

      • INDIA Breast Cancer Core Needle Biopsy Market by Modality Type

        • Ultrasound-Guided
        • Stereotactic
        • Other

      • INDIA Breast Cancer Core Needle Biopsy Market by Procedure Type

        • Outpatient
        • Inpatient

      • INDIA Breast Cancer Core Needle Biopsy Market by Biopsy Device Type

        • Vacuum-Assisted
        • Spring-Loaded
        • Gravity-Fed
      • JAPAN Outlook (USD Billion, 2019-2032)

      • JAPAN Breast Cancer Core Needle Biopsy Market by Target Tissue Type

        • Breast
        • Prostate
        • Lung
        • Liver
        • Kidney

      • JAPAN Breast Cancer Core Needle Biopsy Market by Needle Size Type

        • 14-Gauge
        • 16-Gauge
        • 18-Gauge
        • 20-Gauge
        • 22-Gauge

      • JAPAN Breast Cancer Core Needle Biopsy Market by Modality Type

        • Ultrasound-Guided
        • Stereotactic
        • Other

      • JAPAN Breast Cancer Core Needle Biopsy Market by Procedure Type

        • Outpatient
        • Inpatient

      • JAPAN Breast Cancer Core Needle Biopsy Market by Biopsy Device Type

        • Vacuum-Assisted
        • Spring-Loaded
        • Gravity-Fed
      • SOUTH KOREA Outlook (USD Billion, 2019-2032)

      • SOUTH KOREA Breast Cancer Core Needle Biopsy Market by Target Tissue Type

        • Breast
        • Prostate
        • Lung
        • Liver
        • Kidney

      • SOUTH KOREA Breast Cancer Core Needle Biopsy Market by Needle Size Type

        • 14-Gauge
        • 16-Gauge
        • 18-Gauge
        • 20-Gauge
        • 22-Gauge

      • SOUTH KOREA Breast Cancer Core Needle Biopsy Market by Modality Type

        • Ultrasound-Guided
        • Stereotactic
        • Other

      • SOUTH KOREA Breast Cancer Core Needle Biopsy Market by Procedure Type

        • Outpatient
        • Inpatient

      • SOUTH KOREA Breast Cancer Core Needle Biopsy Market by Biopsy Device Type

        • Vacuum-Assisted
        • Spring-Loaded
        • Gravity-Fed
      • MALAYSIA Outlook (USD Billion, 2019-2032)

      • MALAYSIA Breast Cancer Core Needle Biopsy Market by Target Tissue Type

        • Breast
        • Prostate
        • Lung
        • Liver
        • Kidney

      • MALAYSIA Breast Cancer Core Needle Biopsy Market by Needle Size Type

        • 14-Gauge
        • 16-Gauge
        • 18-Gauge
        • 20-Gauge
        • 22-Gauge

      • MALAYSIA Breast Cancer Core Needle Biopsy Market by Modality Type

        • Ultrasound-Guided
        • Stereotactic
        • Other

      • MALAYSIA Breast Cancer Core Needle Biopsy Market by Procedure Type

        • Outpatient
        • Inpatient

      • MALAYSIA Breast Cancer Core Needle Biopsy Market by Biopsy Device Type

        • Vacuum-Assisted
        • Spring-Loaded
        • Gravity-Fed
      • THAILAND Outlook (USD Billion, 2019-2032)

      • THAILAND Breast Cancer Core Needle Biopsy Market by Target Tissue Type

        • Breast
        • Prostate
        • Lung
        • Liver
        • Kidney

      • THAILAND Breast Cancer Core Needle Biopsy Market by Needle Size Type

        • 14-Gauge
        • 16-Gauge
        • 18-Gauge
        • 20-Gauge
        • 22-Gauge

      • THAILAND Breast Cancer Core Needle Biopsy Market by Modality Type

        • Ultrasound-Guided
        • Stereotactic
        • Other

      • THAILAND Breast Cancer Core Needle Biopsy Market by Procedure Type

        • Outpatient
        • Inpatient

      • THAILAND Breast Cancer Core Needle Biopsy Market by Biopsy Device Type

        • Vacuum-Assisted
        • Spring-Loaded
        • Gravity-Fed
      • INDONESIA Outlook (USD Billion, 2019-2032)

      • INDONESIA Breast Cancer Core Needle Biopsy Market by Target Tissue Type

        • Breast
        • Prostate
        • Lung
        • Liver
        • Kidney

      • INDONESIA Breast Cancer Core Needle Biopsy Market by Needle Size Type

        • 14-Gauge
        • 16-Gauge
        • 18-Gauge
        • 20-Gauge
        • 22-Gauge

      • INDONESIA Breast Cancer Core Needle Biopsy Market by Modality Type

        • Ultrasound-Guided
        • Stereotactic
        • Other

      • INDONESIA Breast Cancer Core Needle Biopsy Market by Procedure Type

        • Outpatient
        • Inpatient

      • INDONESIA Breast Cancer Core Needle Biopsy Market by Biopsy Device Type

        • Vacuum-Assisted
        • Spring-Loaded
        • Gravity-Fed
      • REST OF APAC Outlook (USD Billion, 2019-2032)

      • REST OF APAC Breast Cancer Core Needle Biopsy Market by Target Tissue Type

        • Breast
        • Prostate
        • Lung
        • Liver
        • Kidney

      • REST OF APAC Breast Cancer Core Needle Biopsy Market by Needle Size Type

        • 14-Gauge
        • 16-Gauge
        • 18-Gauge
        • 20-Gauge
        • 22-Gauge

      • REST OF APAC Breast Cancer Core Needle Biopsy Market by Modality Type

        • Ultrasound-Guided
        • Stereotactic
        • Other

      • REST OF APAC Breast Cancer Core Needle Biopsy Market by Procedure Type

        • Outpatient
        • Inpatient

      • REST OF APAC Breast Cancer Core Needle Biopsy Market by Biopsy Device Type

        • Vacuum-Assisted
        • Spring-Loaded
        • Gravity-Fed

    • South America Outlook (USD Billion, 2019-2032)

      • South America Breast Cancer Core Needle Biopsy Market by Target Tissue Type

        • Breast
        • Prostate
        • Lung
        • Liver
        • Kidney

      • South America Breast Cancer Core Needle Biopsy Market by Needle Size Type

        • 14-Gauge
        • 16-Gauge
        • 18-Gauge
        • 20-Gauge
        • 22-Gauge

      • South America Breast Cancer Core Needle Biopsy Market by Modality Type

        • Ultrasound-Guided
        • Stereotactic
        • Other

      • South America Breast Cancer Core Needle Biopsy Market by Procedure Type

        • Outpatient
        • Inpatient

      • South America Breast Cancer Core Needle Biopsy Market by Biopsy Device Type

        • Vacuum-Assisted
        • Spring-Loaded
        • Gravity-Fed

      • South America Breast Cancer Core Needle Biopsy Market by Regional Type

        • Brazil
        • Mexico
        • Argentina
        • Rest of South America
      • BRAZIL Outlook (USD Billion, 2019-2032)

      • BRAZIL Breast Cancer Core Needle Biopsy Market by Target Tissue Type

        • Breast
        • Prostate
        • Lung
        • Liver
        • Kidney

      • BRAZIL Breast Cancer Core Needle Biopsy Market by Needle Size Type

        • 14-Gauge
        • 16-Gauge
        • 18-Gauge
        • 20-Gauge
        • 22-Gauge

      • BRAZIL Breast Cancer Core Needle Biopsy Market by Modality Type

        • Ultrasound-Guided
        • Stereotactic
        • Other

      • BRAZIL Breast Cancer Core Needle Biopsy Market by Procedure Type

        • Outpatient
        • Inpatient

      • BRAZIL Breast Cancer Core Needle Biopsy Market by Biopsy Device Type

        • Vacuum-Assisted
        • Spring-Loaded
        • Gravity-Fed
      • MEXICO Outlook (USD Billion, 2019-2032)

      • MEXICO Breast Cancer Core Needle Biopsy Market by Target Tissue Type

        • Breast
        • Prostate
        • Lung
        • Liver
        • Kidney

      • MEXICO Breast Cancer Core Needle Biopsy Market by Needle Size Type

        • 14-Gauge
        • 16-Gauge
        • 18-Gauge
        • 20-Gauge
        • 22-Gauge

      • MEXICO Breast Cancer Core Needle Biopsy Market by Modality Type

        • Ultrasound-Guided
        • Stereotactic
        • Other

      • MEXICO Breast Cancer Core Needle Biopsy Market by Procedure Type

        • Outpatient
        • Inpatient

      • MEXICO Breast Cancer Core Needle Biopsy Market by Biopsy Device Type

        • Vacuum-Assisted
        • Spring-Loaded
        • Gravity-Fed
      • ARGENTINA Outlook (USD Billion, 2019-2032)

      • ARGENTINA Breast Cancer Core Needle Biopsy Market by Target Tissue Type

        • Breast
        • Prostate
        • Lung
        • Liver
        • Kidney

      • ARGENTINA Breast Cancer Core Needle Biopsy Market by Needle Size Type

        • 14-Gauge
        • 16-Gauge
        • 18-Gauge
        • 20-Gauge
        • 22-Gauge

      • ARGENTINA Breast Cancer Core Needle Biopsy Market by Modality Type

        • Ultrasound-Guided
        • Stereotactic
        • Other

      • ARGENTINA Breast Cancer Core Needle Biopsy Market by Procedure Type

        • Outpatient
        • Inpatient

      • ARGENTINA Breast Cancer Core Needle Biopsy Market by Biopsy Device Type

        • Vacuum-Assisted
        • Spring-Loaded
        • Gravity-Fed
      • REST OF SOUTH AMERICA Outlook (USD Billion, 2019-2032)

      • REST OF SOUTH AMERICA Breast Cancer Core Needle Biopsy Market by Target Tissue Type

        • Breast
        • Prostate
        • Lung
        • Liver
        • Kidney

      • REST OF SOUTH AMERICA Breast Cancer Core Needle Biopsy Market by Needle Size Type

        • 14-Gauge
        • 16-Gauge
        • 18-Gauge
        • 20-Gauge
        • 22-Gauge

      • REST OF SOUTH AMERICA Breast Cancer Core Needle Biopsy Market by Modality Type

        • Ultrasound-Guided
        • Stereotactic
        • Other

      • REST OF SOUTH AMERICA Breast Cancer Core Needle Biopsy Market by Procedure Type

        • Outpatient
        • Inpatient

      • REST OF SOUTH AMERICA Breast Cancer Core Needle Biopsy Market by Biopsy Device Type

        • Vacuum-Assisted
        • Spring-Loaded
        • Gravity-Fed

    • MEA Outlook (USD Billion, 2019-2032)

      • MEA Breast Cancer Core Needle Biopsy Market by Target Tissue Type

        • Breast
        • Prostate
        • Lung
        • Liver
        • Kidney

      • MEA Breast Cancer Core Needle Biopsy Market by Needle Size Type

        • 14-Gauge
        • 16-Gauge
        • 18-Gauge
        • 20-Gauge
        • 22-Gauge

      • MEA Breast Cancer Core Needle Biopsy Market by Modality Type

        • Ultrasound-Guided
        • Stereotactic
        • Other

      • MEA Breast Cancer Core Needle Biopsy Market by Procedure Type

        • Outpatient
        • Inpatient

      • MEA Breast Cancer Core Needle Biopsy Market by Biopsy Device Type

        • Vacuum-Assisted
        • Spring-Loaded
        • Gravity-Fed

      • MEA Breast Cancer Core Needle Biopsy Market by Regional Type

        • GCC Countries
        • South Africa
        • Rest of MEA
      • GCC COUNTRIES Outlook (USD Billion, 2019-2032)

      • GCC COUNTRIES Breast Cancer Core Needle Biopsy Market by Target Tissue Type

        • Breast
        • Prostate
        • Lung
        • Liver
        • Kidney

      • GCC COUNTRIES Breast Cancer Core Needle Biopsy Market by Needle Size Type

        • 14-Gauge
        • 16-Gauge
        • 18-Gauge
        • 20-Gauge
        • 22-Gauge

      • GCC COUNTRIES Breast Cancer Core Needle Biopsy Market by Modality Type

        • Ultrasound-Guided
        • Stereotactic
        • Other

      • GCC COUNTRIES Breast Cancer Core Needle Biopsy Market by Procedure Type

        • Outpatient
        • Inpatient

      • GCC COUNTRIES Breast Cancer Core Needle Biopsy Market by Biopsy Device Type

        • Vacuum-Assisted
        • Spring-Loaded
        • Gravity-Fed
      • SOUTH AFRICA Outlook (USD Billion, 2019-2032)

      • SOUTH AFRICA Breast Cancer Core Needle Biopsy Market by Target Tissue Type

        • Breast
        • Prostate
        • Lung
        • Liver
        • Kidney

      • SOUTH AFRICA Breast Cancer Core Needle Biopsy Market by Needle Size Type

        • 14-Gauge
        • 16-Gauge
        • 18-Gauge
        • 20-Gauge
        • 22-Gauge

      • SOUTH AFRICA Breast Cancer Core Needle Biopsy Market by Modality Type

        • Ultrasound-Guided
        • Stereotactic
        • Other

      • SOUTH AFRICA Breast Cancer Core Needle Biopsy Market by Procedure Type

        • Outpatient
        • Inpatient

      • SOUTH AFRICA Breast Cancer Core Needle Biopsy Market by Biopsy Device Type

        • Vacuum-Assisted
        • Spring-Loaded
        • Gravity-Fed
      • REST OF MEA Outlook (USD Billion, 2019-2032)

      • REST OF MEA Breast Cancer Core Needle Biopsy Market by Target Tissue Type

        • Breast
        • Prostate
        • Lung
        • Liver
        • Kidney

      • REST OF MEA Breast Cancer Core Needle Biopsy Market by Needle Size Type

        • 14-Gauge
        • 16-Gauge
        • 18-Gauge
        • 20-Gauge
        • 22-Gauge

      • REST OF MEA Breast Cancer Core Needle Biopsy Market by Modality Type

        • Ultrasound-Guided
        • Stereotactic
        • Other

      • REST OF MEA Breast Cancer Core Needle Biopsy Market by Procedure Type

        • Outpatient
        • Inpatient

      • REST OF MEA Breast Cancer Core Needle Biopsy Market by Biopsy Device Type

        • Vacuum-Assisted
        • Spring-Loaded
        • Gravity-Fed

     

     

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    No regional reports available for this market.

    No country-specific reports available for this market.

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027